The use of scoring systems in patients with haematological malignancy

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue SUPPL. 451, 2006, Pages 47-51

  Hughes, Derralynn A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Fabry disease; Haematological malignancy; Prognosis; Scoring systems; Staging

Indexed keywords

ADULT; AGED; BONE MARROW CELL; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; DISEASE SEVERITY; FABRY DISEASE; FOLLICULAR LYMPHOMA; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; LYSOSOME STORAGE DISEASE; MAINZ SEVERITY SCORE INDEX; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT INDICATION;

HEALTH STATUS INDICATORS; HEMATOLOGIC DISEASES; HUMANS; IMMUNOGLOBULIN G; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33646704966     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035320600618866     Document Type: Conference Paper

References (10)

1. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-34.
2. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
3. Montillo M, Hamblin T, Hallek M, Montserrat E, Morra E. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies. Haematologica 2005;90:391-9.
4. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54.
5. Hallek M. Risk adapted management of chronic lymphocytic leukemia: update on the cooperative trials of the German Chronic Lymphocytic Leukemia Study Group. Haematologica 2003;88(Suppl 17):26-30.
6. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639-47.
7. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88.
8. Cutler CS, Lee SJ, Greenberg P, Deeg HJ, Perez WS, Anasetti C, et al. A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome. Blood 2004;104:579-85.
9. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-94.
10. Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular Lymphoma International Prognostic Index. Blood 2004;104:1258-65.